Navigation Links
Gates Foundation Adopts Fight against Encephalitis

The fight against Japanese encephalitis, a bird-borne Asian virus that has left a deadly trail of death or more commonly survivors with brain damage has been adopted by the the Bill & Melinda Gates Foundation. //

Today the virus is expanding its geographic reach and threatens several billion people on the planet. Dr. Julie Jacobson, director of the Japanese encephalitis program at Seattle-based Program for Appropriate Technology in Health (PATH) said, "This has been a disease of the world's poor."

According to Jacobson most of those killed or maimed by the virus have gone uncounted, misdiagnosed or regarded as the tragic, inevitable victims of an "orphan disease."

Today, the government of India celebrates with PATH for having immunized 9 million children against Japanese encephalitis that was part of a campaign aimed at reaching 11 million in high-risk districts.

Japanese encephalitis infects the brain and is likely to kill or cause permanent brain damage leading to serious illness in perhaps one in 25 infected, killing 30 percent and causing brain damage in perhaps 40 percent. Because of the poor monitoring of the disease it would be reasonable to expect that the annual death toll of 10,000 is a gross underestimate.

At present there is no viable treatment for the infection. Since children are at highest risk, the children of India are the ones being targeted for immunization.

"This is so exciting," said Jacobson, "For many years, at every twist and turn, it looked impossible. But now it's happening."

Credit for this goes in part to the $27 million grant which the Gates Foundation gave to PATH in 2003 to support a vaccination campaign in Asia. But the real reason behind its recent success is because Jacobson and her colleagues were willing to listen to Indian officials and change course.

In 2000, PATH received $25 million from the Gates Foundation to launch an immunization improv
'"/>




Page: 1 2 3

Related medicine news :

1. Bill Gates to Fund £28m for Malaria researc
2. Bill Gates Takes Personal Interest in AIDS Program
3. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
4. Gates Foundation to donate USD 104 million to TB Alliance
5. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. Clinton, Gates Highlight Treatment, Discrimination of AIDS
8. $68 million aid pours in from Gates Foundation to fight tropical diseases
9. Gates Foundation Grants $23mn for AIDS programme in India
10. Bill Gates pours in funds for diarrhea treatment reseach
11. Gates Foundation Pledges $3 Million to Fight Malaria in Africa

Post Your Comments:
(Date:11/27/2009)... low-emission vehicles may reduce future disease b...27 (HealthDay News) -- Encouraging city dwellers t...er much greater public health benefits than increa...s have found. , The study compared the projecte... transport scenarios for London, England, and Delh...
(Date:11/27/2009)... Specialist manufacturers who use medical load ce...ions of dollars by bringing in technology partner ...mbers of pro-active medical manufacturers are call...age of their projects, ensuring that progress will...r potentially outdated technology. , ...
(Date:11/26/2009)...g drug tetrathiomolybdate (TM) has been shown in s...disease, a disease caused by an overload of copper...wn. Very little, however, is known about how the d...led by Northwestern University researchers now has...l structure of TM bound to copper-loaded metalloch...
(Date:11/26/2009)... Research Triangle Dental (RTDental), a leading d...day announced the expansion of its services to inc.... Doug Macmillan. , Du...eased to announce that Dr. Doug Macmillan, an expe... additional advanced training seminar. RTDental&r...
(Date:11/25/2009)....,Nov.25/PRNewswire-FirstCall/-- OnyxPharmaceutic...ywillhosttwoinvestoreventsinDecember: ,, ASHB....m.ET ,, Principalinvestigatorswilldiscussdat...orrefractorymultiplemyeloma,asfeaturedatthe51stAme...itioninNewOrleans,LA.Theteleconferencewillbeginat9...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...ry Projects, REDWOOD CITY, Calif., Sept. 26 Gene... today that it has obtained,commitments from sever...ly,12.9 million shares of its common stock and war... purchase the,shares and warrants for $1.84 per un...
... and Interdisciplinary Communication With...la., Sept. 26 Eclipsys,Corporation(R) (Nasdaq: E...at Health First, an integrated healthcare delivery...ults include,reduced duplicate documentation, impr...
...s must be very high , , WEDNESDAY, Sept. 2...and acetaminophen (such as Tylenol), taken togethe... This combo produces a byproduct enzyme that,s tox...minophen, the experts added, but also from large d...
...er Breast Cancer Advocates from ...Sept. 26 "Ignite the Promise: Global,Advocate Sum...er activists,from around the world. The Summit wil...ly detection and treatment,options in their countr...
...,President of Ronco Inventions, Inc., has signed a... implement a new international direct sales and,ma...ulletin Board: NNTN).,During his tenure as Preside... remarked, "Tim Dupler has a,proven track record o...
...akes to Take Place at This Year,s Annual C...NAPOLIS, Md., Sept. 26 CBaySystems, a leading,pro..., today announced that,it will be giving away a ne...s to thank the entire HIM community for,helping to...
Other Medicine News:Health News:Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing 2Health News:Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes 2Health News:Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes 3Health News:Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes 4Health News:Caffeine Plus Acetaminophen Toxic for Some 2Health News:Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30 2Health News:Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition 2Health News:CBaySystems to Give Away a 2008 Honda Civic at AHIMA 2007 2
(Date:11/27/2009)...LTLAKECITY,Nov.27/PRNewswire-FirstCall/--Booth-364...,apremiersupplierofX-raytubesandflatpaneldigitalim...heRSNAAnnualMeetinginChicago,Ill.fromNovember29-De...chnologyformultiplemodalitiesaswellasspecializedca...llshowcasethelatestX-raytechnologyincluding: ,,...
(Date:11/25/2009)...NOGAPARK,Calif.,Nov.25/PRNewswire/--PraxisElectron...ricanAcademyofFamilyPhysicians,(AAFP)FamilyPractic...provingmedicalquality,healthmaintenance,anddisease...n.Praxisalsoranked#1amongdoctorsindicatingtheirEMR...,Praxisalsorankednumberoneinthecountryinprovidinge...
(Date:11/25/2009)...INCETON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmas...alcompanycommittedtodiscovering,developingandcomme...dfinancialresultsforthefiscalyearendedSeptember30,...ncash,cashequivalentsandshortterminvestments. ,... ,, Phase2bTrial ,, InlateNovember2009,a...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Scientists Spot Clue to Cancers Aggressiveness 56441 1Lapatinib shows minimal effect against liver cancer 56439 1Lapatinib shows minimal effect against liver cancer 56439 2Lapatinib shows minimal effect against liver cancer 56439 3Team reveals molecular mechanism underlying a form of diabetes 56437 1Team reveals molecular mechanism underlying a form of diabetes 56437 2
...armaceuticals, a privately-held biopharmaceutical ...ollment in the Company,s second pivotal Phase 3 cl... Together with the previously completed first pivo... fully enrolled its planned pivotal Phase 3 studie...e oral therapy currently in development for the tr...
...ut tumor growth and reduced the risk of disease pr... , - Only once-daily oral cancer treatment to dire...ontrols tumor cell division and blood vessel growt...ntial of Afinitor in multiple additional cancers ,...ed today that Afinitor(R) (everolimus) tablets has...
Other Medicine Technology:QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 2Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 3Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 4Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 5Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 6Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 7Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib 8
Urocare® Latex Urinary Leg Bag - Short-Wide
Urocare® Latex Urinary Leg Bag - Large
Medtronic Resting Heart™ System
DLP Recirculation Adapter, Y-Type
Medicine Products: